The-14Sep 24
AI revolutionising fight against cancer and diabetes
#Health #AI #CancerResearch #DiabetesResearch #Biotech #Type1Diabetes #DrugDiscovery #MedicalAI #Healthcare #Immunotherapy #HealthcareInnovation #PrecisionMedicine #DigitalHealth #BiomedicalResearch
https://the-14.com/ai-revolutionising-fight-against-cancer-and-diabetes/
AI revolutionising fight against cancer and diabetes | The-14

AI is transforming cancer and diabetes research by speeding drug discovery, predicting disease risk, and tailoring treatments for safer, more precise care.

The-14 Pictures
MrMed : Online PharmacySep 17

Mounjaro is making headlines. We break down what this dual-action drug means for India’s diabetic population, comparing its efficacy against existing treatments and its long-term viability.
https://www.linkedin.com/pulse/can-indias-diabetic-population-truly-benefit-from-new-arya-jain-4ebpc

#Mounjaro #DiabetesResearch #AffordableHealthcare #IndianHealthcare #DiabetesMedication

Wisdom4theblindSep 8
New discovery by Diabetes Research Institute & Bascom Palmer scientists sheds light on how diabetes causes vision loss.
https://news.med.miami.edu/diabetes-research-institute-bascom-palmer-scientists-reveal-how-diabetes-leads-to-vision-loss/
#DiabetesResearch #VisionLoss #DiabetesAwareness
Diabetes Research Institute, Bascom Palmer Scientists Reveal How Diabetes Leads to Vision Loss - InventUM

A Diabetes Research Institute/Bascom Palmer collaboration resulted in a major step forward in understanding how diabetes damages vision.

InventUM
ScienceOpenAug 29

#ActaMateriaMedica: 'Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus' - an article on #ScienceOpen 🔓📄🔗 https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2025-0020

#BioresponsiveMaterials #GlucoseResponsive #DrugDelivery #DiabetesResearch #Nanomedicine

Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus

<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d3937504e128">Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to biological stimuli such as pH, glucose, enzymes, or temperature, thereby enabling spatiotemporally controlled drug release. This review examines recent progress in the design strategies, activation mechanisms, and therapeutic applications of these materials in diabetes care. Key focus areas include macromolecular insulin delivery systems and oral hypoglycemic agents, with emphasis on their efficacy in regulating blood glucose homeostasis. Despite their promise, challenges persist in translating these technologies to clinical practice, including scalability limitations, insufficient clinical validation, regulatory hurdles, and healthcare system compatibility. Current therapeutic shortcomings, such as frequent injections and adverse effects compromising patient adherence, are discussed. By synthesizing contemporary research developments and implementation barriers, this work provides critical insights into optimizing bioresponsive platforms for clinical translation. Our analysis underscores the need for interdisciplinary approaches to address technical and practical constraints, and ultimately engineer patient-centric, scalable solutions that enhance therapeutic outcomes and quality of life. Future directions include bridging material innovation with clinical needs to develop next-generation diabetes management systems. </p>

ScienceOpen
marc hallAug 20

🔬 20 years ago: Finger pricks & guessing
2024: 3-year implantable sensors coming soon
⚡ Over-the-counter CGMs for non-diabetics
🧠 AI nutrition recommendations
The blood sugar revolution is HERE
https://healthybloodsugarlevels.online/blood-sugar-studies

#BloodSugarStudies
#DiabetesResearch
#MedicalBreakthrough
#ClinicalTrials
#HealthScience
#MedicalStudies
#DiabetesScience

Medical Research on Blood Sugar Levels and Future Trends

Explore our comprehensive guide to medical studies on healthy blood sugar levels. We delve into research from 2000-2020, covering advancements, techniques, and future trends in glucose monitoring and diabetes management.

Healthy Blood Sugar Levels
marc hallAug 5
🧬 Breaking: Stem cell therapy for Type 1 diabetes showing 65-80% improvement rates in trials! Patients going from multiple daily insulin shots to little/no external insulin needed.
The future of diabetes treatment is here - learn about the groundbreaking research →
https://healthybloodsugarlevels.online/stem-cell-diabetes-therapy
#StemCells #Diabetes #Type1Diabetes #MedicalBreakthrough #ClinicalTrials #DiabetesResearch #HealthTech #BetaCells #InsulinFree #DiabetesCure #MedicalInnovation #Healthcare
Stem Cell Therapy for Type 1 Diabetes: Complete Guide 2024 | Clinical Trials & Results

Discover breakthrough stem cell therapy for type 1 diabetes. Learn about mesenchymal stem cells, islet transplantation, clinical trial results, costs & how to access treatment in 2024.

Healthy Blood Sugar Levels
Academic EuropeJul 30

Job Alert

Postdoctoral Researcher (Ph.D./Dr. rer. nat., m/f/div., 100%)

Deadline: 2025-09-30
Location: Germany, Düsseldorf, Nordrhein Westfalen

https://www.academiceurope.com/ads/postdoctoral-researcher-ph-d-dr-rer-nat-m-f-div-e13-tv-l-100/

#hiring #Postdoc #MetabolismResearch #DiabetesResearch #LifeSciences #molecularbiology #biochemistry #physiology

Genomics Daily 🧬🤖Jul 19
🧬🤖 Machine learning cracks diabetes genetic code with 98% accuracy! XGBoost model revolutionizes early detection and personalized medicine. 🩺 #MachineLearning #Genomics #DiabetesResearch https://emmecola.github.io/genomics-daily
Genomics Daily

My GitHub page

Moreno Colaiacovo
Academic EuropeJul 9

Job Alert 🩺

Researcher (Medical doctor) (m/f/div) in the field of energy metabolism

Location: Germany, Düsseldorf, Nordrhein Westfalen

👉 https://www.academiceurope.com/ads/researcher-medical-doctor-m-f-div-in-the-field-of-energy-metabolism-parental-leave-replacement/

#hiring #MedicalResearch #EnergyMetabolism #Postdoc #ClinicalResearch #diabetesResearch #LifeSciences

Innovative Health InitiativeJul 7

⚡ Beta cell therapy offers promise for a cure for type 1 diabetes, but there are still challenges blocking its wider use.

👀 Have you got an innovative solution that could help to accelerate the development of beta cell therapies for type 1 diabetes? Then check out our funding opportunities and start building your consortium!

👉 More info: https://europa.eu/!64JV3K

#DiabetesResearch #HealthResearch #IHITransformingHealth #Diabetes #HorizonEU